TGTX
Price
$31.06
Change
-$2.51 (-7.48%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
VSTM
Price
$4.26
Change
-$0.34 (-7.39%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

TGTX vs VSTM

Header iconTGTX vs VSTM Comparison
Open Charts TGTX vs VSTMBanner chart's image
TG Therapeutics
Price$31.06
Change-$2.51 (-7.48%)
Volume$57.04K
CapitalizationN/A
Verastem
Price$4.26
Change-$0.34 (-7.39%)
Volume$3.94K
CapitalizationN/A
TGTX vs VSTM Comparison Chart
Loading...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TGTX vs. VSTM commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGTX is a Hold and VSTM is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (TGTX: $33.57 vs. VSTM: $4.60)
Brand notoriety: TGTX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TGTX: 86% vs. VSTM: 37%
Market capitalization -- TGTX: $5.23B vs. VSTM: $189.6M
TGTX [@Biotechnology] is valued at $5.23B. VSTM’s [@Biotechnology] market capitalization is $189.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGTX’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • TGTX’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, TGTX is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGTX’s TA Score shows that 5 TA indicator(s) are bullish while VSTM’s TA Score has 3 bullish TA indicator(s).

  • TGTX’s TA Score: 5 bullish, 3 bearish.
  • VSTM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than VSTM.

Price Growth

TGTX (@Biotechnology) experienced а +6.00% price change this week, while VSTM (@Biotechnology) price change was -8.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

TGTX is expected to report earnings on Mar 04, 2025.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.23B) has a higher market cap than VSTM($190M). TGTX YTD gains are higher at: 96.546 vs. VSTM (-43.489). TGTX has higher annual earnings (EBITDA): 5.82M vs. VSTM (-88.92M). TGTX has more cash in the bank: 341M vs. VSTM (113M). VSTM has less debt than TGTX: VSTM (41.4M) vs TGTX (254M). TGTX has higher revenues than VSTM: TGTX (265M) vs VSTM (10M).
TGTXVSTMTGTX / VSTM
Capitalization5.23B190M2,751%
EBITDA5.82M-88.92M-7%
Gain YTD96.546-43.489-222%
P/E Ratio39.56N/A-
Revenue265M10M2,650%
Total Cash341M113M302%
Total Debt254M41.4M614%
FUNDAMENTALS RATINGS
TGTX vs VSTM: Fundamental Ratings
TGTX
VSTM
OUTLOOK RATING
1..100
7173
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
55100
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
3638
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8537

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VSTM's Valuation (77) in the Biotechnology industry is in the same range as TGTX (85). This means that VSTM’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (55) in the Biotechnology industry is somewhat better than the same rating for VSTM (100). This means that TGTX’s stock grew somewhat faster than VSTM’s over the last 12 months.

TGTX's SMR Rating (91) in the Biotechnology industry is in the same range as VSTM (99). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as VSTM (38). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VSTM (100). This means that TGTX’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGTXVSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLCH19.040.22
+1.17%
Franklin FTSE China ETF
IBDS24.04N/A
N/A
iShares iBonds Dec 2027 Term Corp ETF
CLNR23.15N/A
N/A
NYLI Cleaner Transport ETF
EEMA73.43-0.19
-0.26%
iShares MSCI Emerging Markets Asia ETF
CCRV19.88-0.19
-0.97%
iShares® Commodity Curve Carry Strat ETF

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-2.41%
EDIT - TGTX
45%
Loosely correlated
+2.70%
NTLA - TGTX
38%
Loosely correlated
-1.87%
CRNX - TGTX
37%
Loosely correlated
+1.35%
VANI - TGTX
36%
Loosely correlated
-1.52%
ARRY - TGTX
36%
Loosely correlated
+6.01%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with SNSE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-1.71%
SNSE - VSTM
49%
Loosely correlated
+11.97%
GNLX - VSTM
48%
Loosely correlated
+1.69%
ZLDAF - VSTM
47%
Loosely correlated
N/A
TGTX - VSTM
38%
Loosely correlated
-2.41%
MDGL - VSTM
37%
Loosely correlated
-1.58%
More